Skip to content

4Accepted Sep 9, 8:53 PM ET

RxSight (RXST) CMO Ronald M. Kurtz Exchanges Options, Receives Option Awards

RXSTRxSight, Inc.

Accepted (ET)

8:53 PM

Sep 9, 2026

Filed

Sep 9, 2026

Documents

1

Size

24.1 KB

Summary

RxSight (RXST) CMO Ronald M. Kurtz Exchanges Options, Receives Option Awards

Updated

What Happened

  • Ronald M. Kurtz, MD, Chief Medical Officer of RxSight (RXST), participated in the issuer's option exchange program on September 5, 2026. Per the Form 4, he surrendered (dispositions to the issuer) four option lots totaling 902,819 option shares and received four new option awards totaling 686,447 option shares. The transactions are derivative in nature (options), no cash sale/purchase price is reported for the dispositions or awards on the Form 4.
  • The filing notes the post-exchange exercise price for the exchanged awards is $6.375 per share (see footnotes). The new awards remain subject to vesting and continued service requirements described in the footnotes.

Key Details

  • Transaction date: September 5, 2026. Form 4 filed September 9, 2026.
  • Dispositions (surrendered options): 338,819; 200,000; 149,000; 215,000 (total 902,819).
  • Awards (new/options received): 254,751; 173,913; 96,129; 161,654 (total 686,447).
  • Reported post-exchange exercise price: $6.375 per share (footnotes F1, F3, F5).
  • Vesting/conditions: Multiple vesting schedules apply across the new awards (monthly 1/48th vesting from various vesting commencement dates; some awards vest 25% on Feb 28, 2027 with remaining 75% on Aug 31, 2027; see footnotes F2–F9). All awards are conditioned on continued service as defined in the 2021 Equity Incentive Plan.
  • Shares owned after transaction: Not specified on the provided Form 4 excerpt.
  • Transaction codes: D = disposition to issuer (surrendered/exchanged options); A = grant/award (new option awards). These are derivative transactions (options), not open-market purchases or sales of issued shares.

Context

  • These entries reflect an option-exchange program (old options surrendered in exchange for new options at a new strike and vesting schedule). This is an administrative restructuring of equity compensation rather than a cash sale of underlying shares. Because the new awards vest over time and require continued service, they do not represent immediate share ownership or liquidity.
  • No 10b5-1, tax withholding sale, or late-filing indication is stated in the provided details.

AI-written summary · check the filing